Toxoplasma-safe meat : close to reality?KIJLSTRA, Aize; JONGERT, Erik.Trends in parasitology. 2009, Vol 25, Num 1, pp 18-22, issn 1471-4922, 5 p.Article

Control of the risk of human toxoplasmosis transmitted by meatKIJLSTRA, Aize; JONGERT, Erik.International journal for parasitology. 2008, Vol 38, Num 12, pp 1359-1370, issn 0020-7519, 12 p.Article

Functional characterization of in vivo effector CD4⁺ and CD8⁺ T cell responses in acute Toxoplasmosis: An interplay of IFN-γ and cytolytic T cellsJONGERT, Erik; LEMIERE, Arnaud; VAN GINDERACHTER, Jo et al.Vaccine. 2010, Vol 28, Num 13, pp 2556-2564, issn 0264-410X, 9 p.Article

Immunogenicity and safety of the candidate RTS,S/AS01 vaccine in young Nigerian children: A randomized, double-blind, lot-to-lot consistency trialUMEH, Rich; OGUCHE, Stephen; CATTEAU, Gregory et al.Vaccine. 2014, Vol 32, Num 48, pp 6556-6562, issn 0264-410X, 7 p.Article

Evaluation of the Safety and Immunogenicity of the RTS,S/AS01_E Malaria Candidate Vaccine When Integrated in the Expanded Program of ImmunizationAGNANDJI, Selidji T; ASANTE, Kwaku Poku; CHIKAWE, Maria et al.The Journal of infectious diseases. 2010, Vol 202, Num 7, pp 1076-1087, issn 0022-1899, 12 p.Article

Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studiesBIVAS-BENITA, Maytal; LALOUP, Marleen; VERSTEYHE, Soetkin et al.International journal of pharmaceutics. 2003, Vol 266, Num 1-2, pp 17-27, issn 0378-5173, 11 p.Article

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialOLOTU, Ally; LUSINGU, John; VANSADIA, Preeti et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 2, pp 102-109, issn 1473-3099, 8 p.Article

Safety and efficacy of the RTS,S/AS01_E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trialKWAKU POKU ASANTE; ABDULLA, Salim; SALIM, Nahya et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 741-749, issn 1473-3099, 9 p.Article

Induction of partial protection against infection with Toxoplasma gondii genotype II by DNA vaccination with recombinant chimeric tachyzoite antigensROSENBERG, Carina; DE CRAEYE, Stéphane; JONGERT, Erik et al.Vaccine. 2009, Vol 27, Num 18, pp 2489-2498, issn 0264-410X, 10 p.Article